Ponatinib

How is Ponatinib dosed?

The recommended starting dose of Ponatinib is 45 mg once daily. Depending on the patient's response, the dose may be increased to 150 mg once daily after 4 weeks of treatment. Ponatinib should be taken with food to help prevent stomach upset. It is important to follow your doctor's instructions and adjust the dose as needed.

What is the dosage form of Ponatinib?

Ponatinib is available in tablet form.

How is Ponatinib administered?

Ponatinib is administered orally as a tablet and is available only with a doctor's prescription.

What are common precautions when taking Ponatinib?

Common precautions when taking Ponatinib include:

  1. Allergic reactions: Inform your doctor if you have had any allergic reactions to Ponatinib or other medicines.
  2. Difficulty with moving: This medicine may cause difficulty with moving. If you experience any issues with walking or coordination, contact your doctor immediately.
  3. Skin issues: Ponatinib may cause dryness, itching, pain, redness, swelling, tenderness, or warmth on the skin. If any of these occur, consult your healthcare professional.
  4. Lack or loss of strength: This medicine may cause a lack or loss of strength. Inform your doctor if you experience any significant weakness.
  5. Muscle aches, pain, or stiffness: These side effects may occur while taking Ponatinib. Report them to your doctor.
  6. Stuffy or runny nose: This medicine may cause nasal issues. If you have a persistent or severe nasal problem, inform your healthcare provider.
  7. Unlisted side effects: Be aware that other side effects not listed may occur in some patients. If you notice any unusual side effects, contact your healthcare professional.
  8. Age considerations: Appropriate studies have not been performed on the relationship of age to the effects of Ponatinib in the pediatric population. Safety and efficacy have not been established.
  9. Geriatric considerations: Elderly patients may be more likely to experience unwanted effects, which may require caution and an adjustment in the dose for patients receiving Ponatinib.
  10. Breastfeeding: It is not known if Ponatinib is excreted in human breast milk. Consult your doctor before breastfeeding while taking this medicine. Follow your doctor's instructions carefully and seek medical advice if you have any concerns regarding the use of Ponatinib.